<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Endocrine & Infectious Disease | Emergency Care Algorithms 2023</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\(', '\)']],
            displayMath: [['$$', '$$'], ['\[', '\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="06-trauma.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 77.7%;"></div>
                        </div>
                       <span class="progress-text">Part 7 of 9</span>
                    </div>
                    <a href="08-psychiatric-gi-poisoning.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Endocrine & Infectious Diseases</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: algo29 -->
                <section id="algo29" class="content-section" aria-labelledby="section-heading-29">
                    <h2 id="section-heading-29" class="section-heading">
                        <span class="heading-text">29. Hypoglycaemia Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-49-1.jpg" alt="Hypoglycaemia algorithm showing assessment and treatment pathways for conscious and unconscious patients, including oral glucose, IV dextrose, and glucagon administration." class="content-image">
                    </div>
                </section>
                <!-- END: algo29 -->

                <!-- START: algo30 -->
                <section id="algo30" class="content-section" aria-labelledby="section-heading-30">
                    <h2 id="section-heading-30" class="section-heading">
                        <span class="heading-text">30. Hyperglycaemia Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <h4>Hyperglycaemia (RBS >14 mmol/L)</h4>
                        <ul>
                            <li>Monitor, support ABCs</li>
                            <li>Check vital signs (BP, PR, RR, SPO<sub>2</sub>, T°C)</li>
                            <li>Start Oxygen IF SPO<sub>2</sub> &lt;94%. Maintain SPO<sub>2</sub> ≥ 94%</li>
                            <li>Establish IV Access and send samples for Serum Ketones, Venous Blood Gas (VBG)*, UEC and Urinalysis</li>
                            <li>Obtain/review 12-lead ECG (if indicated)</li>
                            <li>Perform brief, targeted, history and physical exam</li>
                            <li><strong>DO NOT GIVE INSULIN</strong></li>
                        </ul>
                        <p><em>*ABG Analysis available in MDCalc. A VBG often correlates well with ABG findings (except for PaO2) unless values are extremely abnormal</em></p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-50-1.jpg" alt="Hyperglycaemia algorithm flow chart for patient management based on diagnosis: known diabetic, new diabetic, or other causes." class="content-image">
                        <div class="table-container">
                           <table class="content-table">
                              <tbody>
                                 <tr>
                                    <td>
                                       - Confirm compliance with medication<br>
                                       - If not compliant, resume previous regimen<br>
                                       - If compliant, optimize dosages<br>
                                       - Advice on lifestyle Modification<br>
                                       - Review RBS daily at nearest facility and keep record<br>
                                       - Review in out-patient medical clinic after 5 days<br>
                                       - Refer to Diabetic clinic if poorly controlled
                                    </td>
                                    <td>
                                       - Lifestyle modification advice<br>
                                       - Start on Metformin as below<br>
                                       - Begin with low-dose metformin - <strong>500 mg BD with meals</strong> (breakfast and/or dinner).<br>
                                       - Review RBS daily at nearest facility and keep record<br>
                                       - Review in out-patient medical clinic after 5 days<br>
                                       - After 5-7 days, if GI side effects have not occurred, advance dose to <strong>850mg</strong> or <strong>1gm</strong> before breakfast and dinner.<br>
                                       - If GI side effects appear as doses advanced, can decrease to previous lower dose and try to advance dose later.<br>
                                       - The maximum effective dose is usually 850 mg BD, with modestly greater effectiveness with doses up to 3 g per day. GI side effects may limit the dose that can be used.<br>
                                       - Refer to Diabetic clinic
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                        </div>
                    </div>
                </section>
                <!-- END: algo30 -->

                <!-- START: algo31 -->
                <section id="algo31" class="content-section" aria-labelledby="section-heading-31">
                    <h2 id="section-heading-31" class="section-heading">
                        <span class="heading-text">31. Diabetic Ketoacidosis (DKA) / Hyperosmolar Hyperglycaemic State (HHS) Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-51-1.jpg" alt="Diagnostic criteria for DKA and HHS, differentiating between the conditions based on serum ketones, pH, bicarbonate, and osmolality." class="content-image">
                        <div class="table-container">
                           <table class="content-table">
                              <thead>
                                 <tr>
                                    <th>1. Fluid Protocol</th>
                                    <th>2. Potassium Protocol</th>
                                 </tr>
                              </thead>
                              <tbody>
                                 <tr>
                                    <td>
                                       <p><strong>If in Shock;</strong><br>Give 20mL/Kg Ringer's Lactate STAT & repeat until perfusion restored (MAP > 65)</p>
                                       <p><strong>If Hypovolaemic but No Shock;</strong><br>Give 15-20 mL/Kg/hr Ringer's Lactate</p>
                                    </td>
                                    <td>
                                       <table class="content-table">
                                          <thead>
                                             <tr>
                                                <th>Serum K+ (mmol/L)</th>
                                                <th>Action</th>
                                             </tr>
                                          </thead>
                                          <tbody>
                                             <tr>
                                                <td>> 5.3</td>
                                                <td>DO NOT give K+, but check potassium levels hourly and start replacement when K+ &lt; 5.3mmol/L</td>
                                             </tr>
                                             <tr>
                                                <td>3.3 to 5.3</td>
                                                <td>Add 20-30 mmol K+/1L fluid/hour to IV fluids until K+ &gt; 4.0-5.0mmol/L</td>
                                             </tr>
                                             <tr>
                                                <td>&lt; 3.3</td>
                                                <td>DO NOT START INSULIN. Add 20-40 mmol K+/1L fluid/hour to IV fluids until K+ > 3.3 mmol/L</td>
                                             </tr>
                                          </tbody>
                                       </table>
                                    </td>
                                 </tr>
                                 <tr>
                                     <td colspan="2">
                                         <h4>3. Insulin Protocol</h4>
                                         <p>Fixed Rate IV Insulin Infusion: <strong>0.1 units/kg/hr</strong><br>e.g. 50 units Actrapid in 50mls Normal Saline at 7mls/hr for a 70Kg patient<br>If RBS does not fall by at least 3mmol/L/hr, double the insulin dose hourly until RBS falls at a steady rate of 3-5 mmol/L/hr.<br>When RBS &lt;14mmol/L:<br>- Add 5% Dextrose to maintenance fluids<br>- Reduce insulin infusion rate to 0.05 units/kg/hr<br>Maintain RBS between 8-12mmol/L until DKA/HHS resolves.</p>
                                         <h4>4. Resolution Criteria</h4>
                                         <p><strong>DKA:</strong> pH > 7.3 and Ketones &lt; 0.6mmol/L<br><strong>HHS:</strong> Osmolality &lt; 300mOsm/Kg and patient eating and drinking</p>
                                     </td>
                                 </tr>
                              </tbody>
                           </table>
                        </div>
                        <div class="callout note">
                           <h4>Useful formulas in DKA (available in MDCalc)</h4>
                           <p>Anion gap = Na<sup>+</sup> - [(Cl<sup>-</sup> + HCO<sub>3</sub><sup>-</sup>)]</p>
                           <p>Serum sodium correction = Na<sup>+</sup> measured + 1.6 * (Glucose - 5.6) / 5.6 (all values in mmol/l)</p>
                           <p>Serum potassium correction during acidaemia = [K+] - (0.6 mmol/L X (7.4 - measured pH) X 10)</p>
                           <p>Serum osmolality (mOsm/L) = 2[Na<sup>+</sup> + K+] (mmol/L) + Glucose (mmol/L) + BUN (mmol/L)</p>
                           <p>Total body water deficit (L) = 0.6<sub>men/children</sub> or 0.5<sub>women</sub> x body weight (kg) x [serum Na<sup>+</sup>/140 - 1]</p>
                        </div>
                    </div>
                </section>
                <!-- END: algo31 -->

                <!-- START: algo32 -->
                <section id="algo32" class="content-section" aria-labelledby="section-heading-32">
                    <h2 id="section-heading-32" class="section-heading">
                        <span class="heading-text">32. Electrolyte Abnormalities Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <ul>
                            <li>Monitor, support ABCs</li>
                            <li>Check vital signs (BP, PR, RR, SPO2, T °C, RBS)</li>
                            <li>Start Oxygen IF SPO<sub>2</sub> &lt;94%. Maintain SPO<sub>2</sub> ≥ 94%</li>
                            <li>Establish IV Access and send blood samples for FBC, UEC</li>
                            <li>Obtain/review 12-lead ECG for K<sup>+</sup> abnormalities</li>
                            <li>Perform brief, targeted history, physical exam</li>
                        </ul>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-52-1.jpg" alt="Title image for electrolyte abnormalities." class="content-image">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Hyponatraemia (&lt;130 mmol/L)</th>
                                        <th>Hypernatremia (&gt;150 mmol/L)</th>
                                        <th>Hypokalaemia (&lt;3 mmol/L)</th>
                                        <th>Hyperkalaemia (&gt;5.5 mmol/l.)</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td colspan="3">For hypotensive patients, give NS/RL <strong>20 mL/kg</strong> bolus and repeat until vital signs are stable</td>
                                        <td>Give calcium to protect the heart (not bind K<sup>+</sup>)<br><strong>10mls 10% Calcium Gluconate</strong> IV over <strong>10min</strong>. Repeat if ECG changes persist.</td>
                                    </tr>
                                    <tr>
                                        <td>
                                            Consult a Physician for ALL Patients<br>
                                            For patients with severe symptoms (vomiting, cardiorespiratory distress, abnormal or deep somnolence, seizures or coma (GCS ≤ 8) (usually in the 100 to 110 mmol/L range), regardless of whether hyponatraemia is acute or chronic: Start IV infusion of <strong>150 ml 3% hypertonic saline</strong> over <strong>20 min</strong>. Repeat infusion checking the serum sodium concentration every 20 min until a target of 5 mmol/l increase in serum sodium concentration is achieved or until the symptoms improve, whichever comes first.
                                        </td>
                                        <td>
                                            Consult a Physician for ALL Patients<br>
                                            After the patient is stabilized, change fluids to D5 ½ NS to provide for maintenance requirements and ongoing losses.
                                        </td>
                                        <td>
                                            <strong>Mild-Moderate hypokalaemia (2-3 mmol/L)</strong><br>
                                            Patients who have mild or moderate hypokalaemia may need only oral potassium replacement therapy if nausea or vomiting is not the cause of the hypokalaemia. Giving <strong>40 to 60 mmol</strong> of elemental potassium orally every 2 to 4 hours for 3 days.
                                        </td>
                                        <td>
                                            1. Check RBS. If RBS &lt; 14 mmol/L, give <strong>50mls 50%</strong> dextrose IV bolus<br>
                                            2. Then give <strong>10units soluble insulin</strong> IV bolus<br>
                                            Repeat 1 & 2 above if repeat K+ is >5.5 mmol/L
                                        </td>
                                    </tr>
                                     <tr>
                                        <td>
                                            Consider using weight-based (2 ml/kg) rather than the fixed 150 ml infusion volumes of 3% hypertonic saline in case of obviously deviant body composition. Keep in mind that if hypokalaemia is present, correction of the hypokalaemia will contribute to an increase in serum sodium concentration. Do not expect patients with severe symptoms to completely recover immediately, as it may take some time for the brain to fully recover.
                                        </td>
                                        <td></td>
                                        <td>
                                            <strong>Severe hypokalaemia (&lt;2 mmol/L)</strong><br>
                                            Patients with severe hypokalaemia or those who cannot tolerate oral supplements will require IV potassium replacement. In general, potassium can be administered at a rate of <strong>10 mmol/hour</strong> in a concentration of no more than <strong>40 mmol/L</strong>. Infusion rates of <strong>20-40 mmol/hour</strong> are acceptable in cases of paralysis or life-threatening arrhythmias.
                                        </td>
                                         <td>
                                            Nebulise Salbutamol <strong>10 to 20 mg</strong> in <strong>4 ml</strong> of NS over <strong>10 minutes</strong> - 25-40% of patients do not respond secondary to tachyphylaxis.
                                         </td>
                                     </tr>
                                     <tr>
                                         <td>Consult a Physician for ALL Patients</td>
                                         <td>Consult a Physician for ALL Patients</td>
                                         <td>Consult a Physician for ALL Patients</td>
                                         <td>Consult a Physician for ALL Patients</td>
                                     </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: algo32 -->
                
                <!-- START: algo33 -->
                <section id="algo33" class="content-section" aria-labelledby="section-heading-33">
                    <h2 id="section-heading-33" class="section-heading">
                        <span class="heading-text">33. Sepsis & Septic Shock Diagnostic Criteria</span>
                    </h2>
                    <div class="content-card">
                        <p>(SOFA and qSOFA Scores available on MDCalc)</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-53-1.jpg" alt="Diagnostic flowchart for Sepsis and Septic Shock, showing the roles of infection suspicion, qSOFA, and SOFA scores." class="content-image">
                        <p>(A) Sequential [Sepsis-Related] Organ Failure Assessment Score <sup>a</sup></p>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>System</th>
                                        <th>0</th>
                                        <th>1</th>
                                        <th>2</th>
                                        <th>3</th>
                                        <th>4</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Respiration</strong><br>PaO<sub>2</sub>/FiO<sub>2</sub>, mm Hg (kPa)</td>
                                        <td>≥ 400 (53.3)</td>
                                        <td>&lt;400 (53.3)</td>
                                        <td>&lt;300 (40)</td>
                                        <td>&lt;200 (26.7) with respiratory support</td>
                                        <td>&lt;100 (13.3) with respiratory support</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Coagulation</strong><br>Platelets, ×10<sup>3</sup>/µL</td>
                                        <td>≥ 150</td>
                                        <td>&lt;150</td>
                                        <td>&lt;100</td>
                                        <td>&lt;50</td>
                                        <td>&lt;20</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Liver</strong><br>Bilirubin, mg/dL (µmol/L)</td>
                                        <td>&lt;1.2 (20)</td>
                                        <td>1.2-1.9 (20-32)</td>
                                        <td>2.0-5.9 (33-101)</td>
                                        <td>6.0-11.9 (102-204)</td>
                                        <td>&gt;12.0 (204)</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Cardiovascular</strong></td>
                                        <td>MAP ≥ 70 mm Hg</td>
                                        <td>MAP &lt;70 mm Hg</td>
                                        <td>Dopamine &lt;5 or dobutamine (any dose)<sup>b</sup></td>
                                        <td>Dopamine 5.1-15 or epinephrine ≤ 0.1 or norepinephrine ≤ 0.1<sup>b</sup></td>
                                        <td>Dopamine &gt;15 or epinephrine &gt;0.1 or norepinephrine &gt;0.1<sup>b</sup></td>
                                    </tr>
                                    <tr>
                                        <td><strong>Central nervous system</strong><br>Glasgow Coma Scale score<sup>c</sup></td>
                                        <td>15</td>
                                        <td>13-14</td>
                                        <td>10-12</td>
                                        <td>6-9</td>
                                        <td>&lt;6</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Renal</strong><br>Creatinine, mg/dL (µmol/L)</td>
                                        <td>&lt;1.2 (110)</td>
                                        <td>1.2-1.9 (110-170)</td>
                                        <td>2.0-3.4 (171-299)</td>
                                        <td>3.5-4.9 (300-440)</td>
                                        <td>&gt;5.0 (440)</td>
                                    </tr>
                                    <tr>
                                        <td>Urine output, mL/d</td>
                                        <td></td>
                                        <td></td>
                                        <td></td>
                                        <td>&lt;500</td>
                                        <td>&lt;200</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p>Abbreviations: Fio, fraction of inspired oxygen: MAP, mean arterial pressure; PaO<sub>2</sub>. partial pressure of oxygen.<br>
                        <sup>a</sup> Adapted from Vincent et al.<sup>27</sup><br>
                        <sup>b</sup> Catecholamine doses are given as µg/kg/min for at least 1 hour.<br>
                        <sup>c</sup> Glasgow Coma Scale scores range from 3-15; higher score indicates better neurological function.</p>
                        <p>The baseline Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score should be assumed to be zero unless the patient is known to have preexisting (acute or chronic) organ dysfunction before the onset of infection. qSOFA indicates quick SOFA; MAP, mean arterial pressure.</p>
                    </div>
                     <div class="content-card">
                        <h3>Sepsis & Septic Shock Algorithm</h3>
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-54-1.jpg" alt="Sepsis and Septic Shock management algorithm, detailing the 'Surviving Sepsis Campaign Bundle' including fluid resuscitation, vasopressors, and antibiotic administration." class="content-image">
                    </div>
                </section>
                <!-- END: algo33 -->
                
                <!-- START: algo34 -->
                <section id="algo34" class="content-section" aria-labelledby="section-heading-34">
                    <h2 id="section-heading-34" class="section-heading">
                        <span class="heading-text">34. Antimicrobial Guide</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <p>For detailed guidelines and other conditions not listed below, refer to your hospital's guidelines for antimicrobial use</p>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr><th>Condition</th><th>Comments/Caveats</th><th>Recommended Therapy</th></tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>URTI/Sinusitis</strong><br>AVOID PRESCRIBING ANTIBIOTICS FOR UPPER RESPIRATORY TRACT INFECTIONS SINCE MOST ARE VIRAL.</td>
                                        <td>The most common cause of URTIs is viral and thus no antibiotics are necessary. A clinician should diagnose Acute Bacterial Rhinosinusitis (ABRS) when a) symptoms or signs of Acute Rhinosinusitis (ARS) persist without evidence of improvement for at least <strong>10 days</strong> beyond the onset of upper respiratory symptoms or b) symptoms or signs of ARS worsen within 10 days after initial improvement (double worsening). DO NOT ORDER A CT SCAN TO DIAGNOSE SINUSITIS</td>
                                        <td>Amoxicillin/Clavulanate 1gm PO BD x 5-10 days is the first-line therapy for most adults who meet the criteria for ABRS. In Penicillin-Allergic Patients: Azithromycin 500 mg PO OD x 3 days. Supportive therapy includes decongestants, saline irrigation, and mucolytics. Antihistamines have no role.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Pharyngitis/Tonsillitis</strong><br>AVOID PRESCRIBING ANTIBIOTICS FOR UPPER RESPIRATORY TRACT INFECTIONS SINCE MOST ARE VIRAL.</td>
                                        <td>The most predictable clinical parameter for GABHS pharyngitis is the Centor Score (available on MDCalc). a) Age &lt; 15 years (+1) or ≥ 45 years (-1) b) History of fever >38°C c) Absence of cough, d) Swollen and tender anterior cervical lymph nodes e) Tonsillar exudates or swelling</td>
                                        <td>Adult patients with acute exudative adult pharyngitis who report ≥ 4 Centor Score ONLY: Benzathine penicillin G 1.2MU IM stat OR Amoxicillin/Clavulanate 1 gm PO BD x 5-10 days. Consider single-dose Prednisone 60 mg PO or Dexamethasone 8 mg IM. Penicillin allergic: Azithromycin 500 mg PO on day 1 followed by 250 mg PO OD for 4 days.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Laryngitis</strong></td>
                                        <td>Mostly viral</td>
                                        <td>No Antibiotics necessary</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Acute Gastroenteritis</strong><br>AVOID PRESCRIBING ANTIBIOTICS FOR ACUTE GASTROENTERITIS WITHOUT SYSTEMIC DISEASE OR DYSENTERY</td>
                                        <td>Evaluation of faecal specimen needed for diarrhoea lasting > 1 day with features like bloody diarrhoea, moderate-severe disease, symptoms >7 days, immunocompromised patients, recent antibiotic use. Stool culture not cost-effective in most cases. Typhoid diagnosis is complex.</td>
                                        <td>Supportive treatment usually sufficient. Antibiotics can prolong carrier state in salmonellosis. Treat ONLY patients with specific criteria: Ciprofloxacin <strong>500 mg PO BD x 3 days</strong>. Loperamide may reduce duration but should be restricted to non-bloody stool.</td>
                                    </tr>
                                    <tr>
                                       <td><strong>Urinary Tract Infection (UTI)</strong></td>
                                       <td>Cloudiness/odor of urine is not definitive. A negative Leukocyte Esterase AND a negative urine Nitrate largely rule out infection. Asymptomatic Bacteriuria is NOT an indication for therapy. Urine cultures ONLY for pyelonephritis or complicated UTIs. Complicated UTI factors include male gender, structural abnormalities, catheters, etc.</td>
                                       <td><strong>Uncomplicated Cystitis:</strong> Ciprofloxacin 500 mg PO BD x 3 days OR Nitrofurantoin 100 mg TDS x 3 days.<br><strong>Uncomplicated Pyelonephritis (Outpatient):</strong> Ceftriaxone 1 g IV stat PLUS Ciprofloxacin 500 mg PO BD x 7 days.<br><strong>UTI in Pregnancy (Outpatient):</strong> Cefuroxime 500 mg PO BD for 7 days OR Nitrofurantoin 100 mg TDS x 3 days.</td>
                                    </tr>
                                    <tr>
                                       <td><strong>Sepsis & Septic Shock</strong></td>
                                       <td>See Sepsis & Septic Shock Algorithm</td>
                                       <td>Give ANTIBIOTICS as an EMERGENCY (within the FIRST HOUR of recognition).<br>- Ceftriaxone 2gm IV stat.<br>For probable Neutropenic patients or Hospital Acquired Infection:<br>- Imipenem 500 mg IV infusion over 3 hrs then QID<br>OR<br>- Meropenem 1 gm IV infusion over 3 hrs then TDS for possible CNS infections.</td>
                                    </tr>
                                     <tr>
                                       <td><strong>Community-Acquired Pneumonia</strong></td>
                                       <td>Diagnosis requires demonstrable infiltrate on imaging. Blood cultures indicated for severe CAP. Comorbidities increase risk. Inpatient therapy for CURB65 ≥ 2. Consider HCAP risk factors.</td>
                                       <td><strong>Outpatient:</strong> Amoxicillin/Clavulanate 1 gm PO BD x 7-10 days. (Allergic: Azithromycin).<br><strong>Inpatient:</strong> Amoxicillin/Clavulanate 1.2 gm IV TDS x 7-10 days. (+ Azithromycin 500 mg IV OD for severe cases).<br><strong>HCAP:</strong> Antipseudomonal beta-lactam e.g., Imipenem 500 mg IV QID.</td>
                                    </tr>
                                     <tr>
                                       <td><strong>Malaria</strong></td>
                                       <td>Criteria for severe malaria include prostration, multiple convulsions, acidosis, hypoglycaemia, severe anaemia, renal impairment, jaundice, pulmonary oedema, significant bleeding, shock, and hyperparasitaemia.</td>
                                       <td><strong>Uncomplicated:</strong> Artemether + Lumefantrine (Coartem®) dosed by weight for 3 days.<br><strong>Severe:</strong> IV Artesunate <strong>2.4mg/kg</strong> at 0, 12, and 24 hours, then daily. Children &lt; 20 kg need higher dose (3 mg/kg).</td>
                                    </tr>
                                     <tr>
                                       <td><strong>Community-Acquired Severe Intra-Abdominal Infection, Biliary, and Extra-Biliary Infections</strong></td>
                                       <td>Empiric coverage of Enterococcus is recommended</td>
                                       <td>Piperacillin-Tazobactam 4.5 gm IV QID</td>
                                    </tr>
                                    <tr>
                                       <td><strong>Cellulitis/ Abscesses/ Folliculitis/ Carbuncle/ Furuncle</strong></td>
                                       <td>Most abscesses are Staph aureus. Most cellulitis is Group A beta-haemolytic streptococcus. Effective treatment of abscesses is I&D. Systemic antibiotics are rarely indicated unless extensive cellulitis, fever, etc.</td>
                                       <td><strong>Oral Therapy:</strong> Amoxicillin/Clavulanate 1gm PO BD x 7 days OR Clindamycin 450 mg PO QID x 7-10 days.<br><strong>Parenteral Therapy (Inpatient):</strong> Cefazolin 1gm IV q8 hours OR Clindamycin 600 mg IV q8 hours for 7-10 days.</td>
                                    </tr>
                                     <tr>
                                       <td><strong>Necrotizing skin & soft tissue infections</strong></td>
                                       <td>Surgical intervention is the major therapeutic modality. Can be Group A Strep/Staph or polymicrobial.</td>
                                       <td>Consult a Surgeon</td>
                                    </tr>
                                     <tr>
                                       <td><strong>STI - Urethritis, Epididymitis, Orchitis, Proctitis, Cervicitis</strong></td>
                                       <td>Minimum criteria for clinical diagnosis of PID (all 3 present): bilateral lower abdominal tenderness, cervical motion tenderness, bilateral adnexal tenderness.</td>
                                       <td><strong>STI:</strong> Ceftriaxone 500 mg IM stat PLUS Azithromycin 1gm PO stat.<br><strong>PID (Mild-Moderate):</strong> Ceftriaxone 500 mg IM stat + Doxycycline 100 mg PO BD x 14 days + Metronidazole 500 mg PO BD x 14 days.<br><strong>PID (Severe/Inpatient):</strong> Ceftriaxone 1 gm IV OD x 14 days + Doxycycline 100 mg IV/PO BD x 14 days + Metronidazole 500 mg PO BD x 14 days.</td>
                                    </tr>
                                     <tr>
                                        <td><strong>HIV Post Exposure Prophylaxis (PEP)</strong></td>
                                        <td>Must be HIV negative at baseline, exposure within 72 hrs, high-risk exposure. Faeces, saliva, urine, etc., not infectious unless visibly bloody. Risk varies by exposure route. Counsel on risks/benefits, perform baseline tests, offer Hep B vax.</td>
                                        <td>Initiate within 72 hrs. Continue for 28 days.<br><strong>ADULTS:</strong> Tenofovir/Lamivudine (TDF/3TC) + Dolutegravir (DTG). Use Atazanavir/Ritonavir (ATV/r) instead of DTG in women/girls of childbearing potential.<br><strong>CHILDREN:</strong> Abacavir/Lamivudine (ABC/3TC) + Lopinavir/Ritonavir (LPV/r). Follow up at 7, 14, 28 days and HIV testing at 3 and 6 months.</td>
                                     </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: algo34 -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="06-trauma.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 77.7%;"></div>
                        </div>
                       <span class="progress-text">Part 7 of 9</span>
                    </div>
                    <a href="08-psychiatric-gi-poisoning.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>